ES2527341T3 - Bioprecursor a base de polifenol - Google Patents

Bioprecursor a base de polifenol Download PDF

Info

Publication number
ES2527341T3
ES2527341T3 ES06778610.3T ES06778610T ES2527341T3 ES 2527341 T3 ES2527341 T3 ES 2527341T3 ES 06778610 T ES06778610 T ES 06778610T ES 2527341 T3 ES2527341 T3 ES 2527341T3
Authority
ES
Spain
Prior art keywords
polyphenol
acid
phenyl
bioprecursor
diacetoxystyryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES06778610.3T
Other languages
English (en)
Spanish (es)
Inventor
Sabine Delaire
Adrien Adao
Jean-Roger Desmurs
Mirjana Gelo-Pujic
Laurent Saint-Jalmes
Tarek Kassem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Rhodia Chimie SAS
Chanel Parfums Beaute SAS
Original Assignee
Rhodia Chimie SAS
Chanel Parfums Beaute SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhodia Chimie SAS, Chanel Parfums Beaute SAS filed Critical Rhodia Chimie SAS
Application granted granted Critical
Publication of ES2527341T3 publication Critical patent/ES2527341T3/es
Anticipated expiration legal-status Critical
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/18—Antioxidants, e.g. antiradicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/205—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings
    • C07C39/21—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring polycyclic, containing only six-membered aromatic rings as cyclic parts with unsaturation outside the rings with at least one hydroxy group on a non-condensed ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/40—Succinic acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/734—Ethers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/88—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with esterified carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/84—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring
    • C07C69/92—Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring of monocyclic hydroxy carboxylic acids, the hydroxy groups and the carboxyl groups of which are bound to carbon atoms of a six-membered aromatic ring with etherified hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES06778610.3T 2005-06-17 2006-06-16 Bioprecursor a base de polifenol Active ES2527341T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0506169 2005-06-17
FR0506169A FR2887251B1 (fr) 2005-06-17 2005-06-17 Bioprecurseur a base de polyphenol
PCT/FR2006/001375 WO2006134282A1 (fr) 2005-06-17 2006-06-16 Bioprecurseur a base de polyphenol

Publications (1)

Publication Number Publication Date
ES2527341T3 true ES2527341T3 (es) 2015-01-22

Family

ID=35788537

Family Applications (1)

Application Number Title Priority Date Filing Date
ES06778610.3T Active ES2527341T3 (es) 2005-06-17 2006-06-16 Bioprecursor a base de polifenol

Country Status (6)

Country Link
US (1) US9067908B2 (https=)
EP (1) EP1893555B1 (https=)
JP (1) JP5469339B2 (https=)
ES (1) ES2527341T3 (https=)
FR (1) FR2887251B1 (https=)
WO (1) WO2006134282A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005069998A2 (en) 2004-01-20 2005-08-04 Brigham Young University Technology Transfer Office Novel sirtuin activating compounds and methods for making the same
US8344024B2 (en) 2007-07-31 2013-01-01 Elc Management Llc Anhydrous cosmetic compositions containing resveratrol derivatives
US20090035240A1 (en) * 2007-07-31 2009-02-05 Maes Daniel H Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent
US9295621B2 (en) 2007-07-31 2016-03-29 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant
US20090035236A1 (en) 2007-07-31 2009-02-05 Maes Daniel H Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And An Oil Phase Structuring Agent
US8080583B2 (en) 2007-07-31 2011-12-20 Elc Management Llc Emulsion cosmetic compositions containing resveratrol derivatives and linear or branched silicone
WO2009017866A1 (en) * 2007-07-31 2009-02-05 Elc Management Llc Cosmetic compositions containing resveratrol derivatives
CN102617348B (zh) * 2007-09-08 2016-05-18 Elc管理有限责任公司 阿魏酸白藜芦醇酯化合物、包含该化合物的组合物及其使用方法
FI125590B (en) 2008-04-10 2015-12-15 Neste Oyj A process for the preparation of a composition for the preparation of pinosylvine and its compounds, a composition for the preparation of stilbene compounds, a process for the recovery of stilbene compounds, and fatty acid and resin acid esters of pinosylvine and its monomethyl ether
EP2429481A4 (en) * 2008-06-25 2014-08-13 Elc Man Llc METHOD AND COMPOSITIONS FOR IMPROVING THE APPEARANCE OF SKIN AND BODY
KR101063876B1 (ko) 2009-03-03 2011-09-08 한밭대학교 산학협력단 신규 리포익산/폴리페놀 컨쥬게이트 화합물 및 그의 용도
KR101515692B1 (ko) * 2009-10-05 2015-04-27 닛본 덴끼 가부시끼가이샤 셀룰로오스 수지 및 그 제조 방법
US20120237941A1 (en) 2009-12-07 2012-09-20 Chanel Parfums Beaute Method for screening active agents that stimulate the expression of arnt2 to improve the skin's barrier function
US8030432B2 (en) * 2009-12-10 2011-10-04 The United States Of America As Represented By The Secretary Of The Army Copolymerization of hydroxytyrosol with flavonoids mediated by horseradish peroxidases
US8134020B2 (en) * 2009-12-10 2012-03-13 The United States Of America As Represented By The Secretary Of The Army Polymerization of hydroxytyrosol mediated by horseradish peroxidases
US8715651B2 (en) 2010-01-08 2014-05-06 Chanel Parfums Beaute Use of at least one extract of flowers of Camellia japonica alba plena for moisturizing the skin
JP2013528574A (ja) * 2010-04-12 2013-07-11 ベルケム エス．ア． 安定化ポリフェノール誘導体、その生産方法、及びその使用
FR2959230B1 (fr) 2010-04-27 2016-03-25 Chanel Parfums Beaute Polypeptide exprime dans la couche cornee et son utilisation
WO2012070656A1 (ja) * 2010-11-26 2012-05-31 ユーハ味覚糖株式会社 生理活性を有するヒドロキシスチルベン誘導体の製造方法
CN103619311B (zh) 2011-06-16 2016-01-20 香奈儿香水美妆品公司 半透明糖浆状化妆品组合物
FR2989271B1 (fr) * 2012-04-12 2014-08-22 Chanel Parfums Beaute Composition stable comprenant un compose anti-age et un solvant
US9187402B2 (en) 2012-06-14 2015-11-17 North Carolina Agricultural And Technical State University Aspirin derivatives and uses thereof
KR101480600B1 (ko) * 2013-01-22 2015-01-08 경북대학교 산학협력단 레스베라트롤 유도체의 피부미백 용도
ES2786306T3 (es) * 2014-02-06 2020-10-09 Biocogent Llc Composiciones y métodos mejorados que comprenden resveratrol
WO2015162265A1 (en) * 2014-04-24 2015-10-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) New lipophenol compounds and uses thereof
GB201416273D0 (en) * 2014-09-15 2014-10-29 Isis Innovation Therapeutic compounds
KR101601685B1 (ko) * 2015-08-24 2016-03-09 여명바이오켐 주식회사 항산화 효과가 우수한 택시폴린 유도체 및 이를 함유하는 화장료 조성물
US9844526B2 (en) * 2015-10-28 2017-12-19 Gateway Health Alliances, Inc. Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma
US9782375B2 (en) * 2015-10-28 2017-10-10 Shil Kothari Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma
US11241396B2 (en) * 2015-10-28 2022-02-08 Gateway Health Alliances, Inc. Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma
US10851042B2 (en) 2016-03-07 2020-12-01 Elc Management Llc Solubization of resveratrol glycolate and tartrate derivatives
AU2017229094B2 (en) * 2016-03-07 2019-10-10 Elc Management Llc Resveratrol glycolate and tartrate derivatives and synthetic methods therefor
GR20180100094A (el) 2018-03-07 2019-10-16 Εθνικο Ιδρυμα Ερευνων Βιο-εμπνευσμενοι ενεργοποιητες του πρωτεασωματος με αντιγηραντικη δραση
CA3116556A1 (en) 2018-10-16 2020-04-23 President And Fellows Of Harvard College Sirt1 activating compounds
FR3094224B1 (fr) 2019-03-29 2021-05-28 Chanel Parfums Beaute Composition permettant le transfert d’un motif coloré sur la peau et utilisations
FR3094222B1 (fr) 2019-03-29 2021-09-10 Chanel Parfums Beaute Composition cosmétique longue tenue
FR3094228B1 (fr) 2019-03-29 2022-04-01 Chanel Parfums Beaute Base de teint conférant un maquillage longue tenue
FR3094226B1 (fr) 2019-03-29 2021-11-26 Chanel Parfums Beaute Composition cosmétique longue tenue
FR3094220B1 (fr) 2019-03-29 2022-02-25 Chanel Parfums Beaute Composition cosmétique filmogène pelable
FR3096581B1 (fr) 2019-05-31 2021-10-22 Chanel Parfums Beaute Gel aqueux solide comprenant un mélange de gomme de xanthane et de gomme de carroube
FR3098108B1 (fr) 2019-07-03 2022-04-01 Chanel Parfums Beaute Composition cosmétique solide longue tenue
FR3098110B1 (fr) 2019-07-03 2022-02-04 Chanel Parfums Beaute Composition cosmétique solide
FR3098107B1 (fr) 2019-07-03 2022-07-29 Chanel Parfums Beaute Composition cosmétique solide
FR3098109B1 (fr) 2019-07-03 2022-02-04 Chanel Parfums Beaute Composition cosmétique solide hydratante
EP3895683A1 (fr) 2020-04-14 2021-10-20 Chanel Parfums Beauté Composition cosmétique multi-phases comprenant au moins deux phases huileuses non miscibles
CN119751414A (zh) * 2024-12-23 2025-04-04 江苏同禾药业有限公司 一种具有抗氧化和抗炎功能的硫辛酸衍生物及其制备方法与应用
CN120866433B (zh) * 2025-09-26 2025-12-30 杭州媄丽媄生物技术有限公司 改性羟基酪醇、化妆品、制备方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5935884B2 (ja) * 1980-10-27 1984-08-31 株式会社 薬理学中央研究所 ピラノンを含有するメラニン生成抑制剤
JPS5879951A (ja) * 1981-11-06 1983-05-13 Yasuaki Fukuda トロポロンの脂肪酸エステルおよび該エステルを有効成分とする美白化粧料
TW197375B (https=) * 1990-11-19 1993-01-01 Hayashibara Biochem Lab
FR2725897B1 (fr) * 1994-10-24 1996-12-06 Oreal Produit pour application topique contenant une lipase et un precurseur d'actif
FR2750328B1 (fr) * 1996-06-28 1998-08-14 Oreal Composition cosmetique et/ou dermatologique contenant au moins un precurseur d'actif et un poly(acide 2 -acrylamido 2 -methylpropane sulfonique) reticule
FR2766176B1 (fr) * 1997-07-15 1999-10-29 Caudalie Compositions a base de derives de resveratrol
FR2778663B1 (fr) * 1998-05-15 2001-05-18 Coletica Nouveaux esters de flavonoides,leur utilisation en cosmetique, dermopharmacie, en pharmacie et en agro-alimentaire
FR2789577B1 (fr) * 1999-02-17 2002-04-05 Oreal Utilisation de derives substitues en 3 du stilbene comme actifs deodorants dans les compositions cosmetiques
DE10056400A1 (de) * 2000-11-14 2002-05-23 Merck Patent Gmbh Galenische Formulierung
JP2003055314A (ja) * 2001-08-20 2003-02-26 Fujita Masao ヒドロキシけい皮酸誘導体及びこれを用いた抗酸化剤

Also Published As

Publication number Publication date
FR2887251A1 (fr) 2006-12-22
JP5469339B2 (ja) 2014-04-16
JP2008546675A (ja) 2008-12-25
WO2006134282A1 (fr) 2006-12-21
EP1893555B1 (fr) 2014-10-29
US20090215881A1 (en) 2009-08-27
FR2887251B1 (fr) 2008-02-01
EP1893555A1 (fr) 2008-03-05
US9067908B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
ES2527341T3 (es) Bioprecursor a base de polifenol
US5536500A (en) Monoesters and diesters of cinnamic acid or of one of the derivatives thereof and of vitamin c, process for the preparation thereof, and use as antioxidants in cosmetic, pharmaceutical or nutritional compositions
JP3241440B2 (ja) 化粧料
CA2705840A1 (fr) Compositions de derives polyphenoliques stilbeniques et leurs applications pour lutter contre les pathologies et le vieillissement des organismes vivants
JP2007524675A (ja) 配合助剤
ES2365168T3 (es) Nuevas aplicaciones cosméticas de polifenoles y de sus derivados.
US7871987B2 (en) Ester derivatives of ascorbic and 2-keto acid saccharides
AU4267500A (en) Topical cosmetic compositions comprising benzaldoximes
KR100760875B1 (ko) 멜라닌 생성 억제 피부미백용 화장품 조성물
CA2705838A1 (fr) Compositions de derives polyphenoliques flavonoidiques et leurs applications pour lutter contre les pathologies et le vieillissement des organismes vivants
ES2781865T3 (es) Compuestos de la familia de N-acilamino-amidas, composiciones que los comprenden, y usos
WO2012051741A1 (zh) 抑制黑色素生成的甘胺酸衍生物及其美白组合物
US20240245600A1 (en) Orris root extracts, compositions, and methods for skin applications
CN101420929B (zh) 皮肤化妆料
JP4763232B2 (ja) 皮膚外用剤
ES2275923T3 (es) Bioprecursores para aplicacion percutanea.
JP4879344B1 (ja) 抗酸化性ポリヒドロキシベンゼン誘導体および抗炎症用皮膚外用剤
KR101832415B1 (ko) 레티노이드 유도체를 유효성분으로 함유하는 피부 미백용 화장료 조성물
US5505936A (en) Phosphoric diesters which absorb UV rays, method of preparing the same, and cosmetic compositions containing the same
JP4959914B2 (ja) 皮膚外用剤
JP3503205B2 (ja) チロシナ−ゼ活性阻害剤並びに皮膚保湿剤
WO2006032122A1 (en) An antioxidant complex and a cosmetic and pharmaceutical composition comprising said complex
KR100820575B1 (ko) 플라보노이드계 화합물을 포함하는 피부 미백용 조성물
JPH0967225A (ja) 皮膚外用剤
KR100740575B1 (ko) 2,3-디히드록시벤조산 유도체 화합물과 그 제조방법 및이를 함유하는 미백 화장료 조성물